EarningsQ4 2026 Earnings Report
CFIGF Q4 2026 EPS Results
Actual EPS$0.23
Consensus EPS$0.23
Beat/MissMissed by -<$0.01
One Year Ago EPS$0.22
CFIGF Q4 2026 Revenue Results
Actual Revenue$768.40M
Expected Revenue$352.26M
Beat/MissBeat by +$416.14M
YoY Revenue Growth-22.33%
Earnings Announcement Details
QuarterQ4 2026
Date08/17/2026
TimeAfter Close
Conference CallMonday, August 17, 2026
CFIGF Upcoming Earnings
Challenger 's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
CFIGF Q4 2026 Earnings Call
0:00 / 0:00
Q4 2026 Earnings Slide Deck
Q4 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlighted strong execution and momentum: record annuity and Life sales, disciplined cost management, upgraded credit ratings, improved capital resilience under new APRA standards, increased dividends and an upsized buyback, and a clear medium-term growth and ROE outlook. Challenges noted included persistently tight credit spreads that compress near-term yields, temporary increases in maturity rates from opportunistic short-dated business, transitional costs, and greater volatility in reported investment returns under the new framework. Overall the positives (growth in sales, improved capital position, higher dividends, strategic partnerships and distribution expansion) materially outweigh the operational and market headwinds.Company Guidance
Normalized Earnings and EPS Growth
Normalized net profit after tax of $468 million and normalized EPS of $0.681, both up 3% year-on-year, demonstrating steady underlying earnings growth under the previous reporting basis.
Strong Statutory Result Driven by Positive Experience
Statutory NPAT of $506 million, up 163% year-on-year, driven by positive asset and liability experience and partial unwind of prior AASB 17 non-economic mismatch.
Dividend Increase and Capital Return
Full-year ordinary dividend increased 7% to $0.315 per share plus a fully franked special dividend of $0.015 per share; on-market buyback program upsized to $450 million (subject to APRA approval) after repaying over half of hybrid capital.
Record and Growing Annuity Sales
Total Life sales grew 12% to $9.6 billion; annuity book grew 10.7%; long-dated (3+ year) annuity sales increased to $3.2 billion and long-dated sales rose 14%, with retail lifetime and reinsurance sales at record levels.
Expanded Distribution Channels and Successful Issuances
Secured three major retirement partnerships (Insignia, BT, CFS) unlocking access to >2 million customers and ~$0.5 trillion in partner AUM; launched inaugural ASX LiFTS note (closed $350 million, >3x oversubscribed) and inaugural CABN institutional term annuity-backed note of $750 million (order book >$1.75 billion).
Offshore Reinsurance and Strategic Ventures
Expanded offshore reinsurance platform (Calix Re) now licensed and rated to access Asian annuity markets; strategic equity stakes in Fidante-Channel Capital (to hold 45% pro forma) and advice technology investments (Ignition, IF) to address advice gap and scale retirement advice.
Capital Strength and Improved Regulatory Positioning
Pro forma Prescribed Capital Amount (PCA) under new capital standards is 1.5x (reported PCA 1.38x); revised target PCA range 1.15–1.35x under new standards. S&P upgraded ratings: Challenger Life Company to A+ and Challenger Limited to A-, the strongest in company history.
Cost Discipline and Operating Efficiency
Total expenses held to $319 million with a cost-to-income ratio of 32.1% (improving 20 basis points), at the bottom of the 32%–34% target range, evidencing operating leverage and scalable platform capability.
Asset Origination and AUM Growth Ambition
Investment teams originated more than $10 billion during the year; combined balance sheet and asset management AUM of $31 billion (excluding Fidante) with a target of $50 billion by 2030.
Clear Forward Guidance and Medium-Term Targets
FY27 core EPS guidance of $0.45–$0.49 (midpoint ~6% growth on comparable FY26 core EPS $0.442); medium-term targets include operating EPS compound growth of 8%–10% over 3–5 years, operating ROE target of 12%–14%, and dividend payout 65%–75% of core EPS.
CFIGF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed